Fraxiparine (Nadroparin Calcium)

Fraxiparine is a low-molecular-weight heparin used for anticoagulation. It is administered via haemodialysis, intravenous, or subcutaneous routes. Learn more about its uses and effects.

Fraxiparine, containing Nadroparin Calcium, is primarily used for anticoagulation to prevent blood clots. It is often prescribed for patients undergoing haemodialysis or those at risk of thromboembolic events. The medication works by inhibiting certain clotting factors in the blood. Fraxiparine is also used in surgical settings to reduce the risk of clot formation during and after procedures.

Common effects of Fraxiparine may include bruising, bleeding, and pain at the injection site. Some users might experience allergic reactions or changes in blood cell counts. It is important to monitor for signs of unusual bleeding or bruising while using this medication.

Fraxiparine should be handled with care to avoid contamination. It is essential to follow the prescribed administration route, whether haemodialysis, intravenous, or subcutaneous. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Fraxiparine may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always consult a healthcare provider before combining Fraxiparine with other medications.